42nd week of 2021 patent applcation highlights part 8 |
Patent application number | Title | Published |
20210322254 | Bodyweight Unloading Locomotive Device - A bodyweight unloading locomotive device includes a frame configured to support locomotive movement, and an unloading assembly carried by the frame. The unloading assembly includes a spring having a fixed end coupled to the frame and an opposed free end, a cam assembly mounted to the frame for rotational movement, a first tether extending from the free end of the spring to the cam assembly, and a second tether extending from the cam assembly to a load. The unloading assembly exerts an unloading force on the load with respect to the frame. | 2021-10-21 |
20210322255 | MASSAGE PIN FOR SKIN BLOOD CIRCULATION PROMOTER AND COUPLING METHOD THEREOF - A massage pin for skin blood circulation promoters has a lower end to/from which a silver conductor having stable electrical resistance is coupled or separated by a user of a skin blood circulation promoter, as needed. The massage pin includes: a coupling portion formed at an upper end of the massage pin and press-fitted into a circuit board disposed between a main body and a cover of a blood circulation promoter, the coupling portion being formed of a conductive rubber. An exposed portion extends from a lower end of the coupling portion and is exposed outside through a massage pin-passage hole formed through the cover. The exposed portion has a downwardly tapered connection portion extending from a lower end thereof and includes a silver conductor detachably coupled to the connection portion. The conductor has a reception portion open at an upper portion thereof. | 2021-10-21 |
20210322256 | EXTERNAL COUNTERPULSATION SYSTEM AND METHOD FOR CONTROLLING SAME - The present invention relates to an external counterpulsation system which senses a biosignal to monitor a heart condition and performs external counterpulsation in response to the monitored heart condition. The present invention comprises: a compression device surrounding limbs of a subject to compress the surrounded limbs or release the limbs from the compression; and a control device which controls the compression device to apply test compression to the limbs for a predetermined test period with predetermined test intensity before performing the external counterpulsation, configures personalized maximum compression intensity corresponding to the subject through the test compression, and controls the compression device to perform the external counterpulsation on the basis of the configured maximum compression intensity. | 2021-10-21 |
20210322257 | Gentle and Flexible Massage Head for Percussion Massager - A massage head for use on a percussion massager in order to provide a gentle and body-contour-following massage, includes a plurality of flexible arms extending radially away from the reciprocation axis, and a soft dome made of hollow silicone rubber, soft foam, or the like at the end of each arm. Centrally located among the massage features and on the reciprocation axis is an additional soft dome that is recessed from the massage features, and contacts the skin of the subject being massaged in order to prevent the hard frame of the massage head from “bottoming out” on the subject when the arms flex too much. The massage head also has a ball joint that allows the massage head to pivot relative to the reciprocation axis, allowing the massage head to more closely follow the body contours of the subject. | 2021-10-21 |
20210322259 | Massaging Cushion System - A massaging cushion system for vibrating a personal cushion includes a personal electronic device that has vibration capabilities such that the personal electronic device is actuatable to vibrate. A cushion is provided and the cushion has a pocket integrated therein. The pocket insertably receives the personal electronic device. The cushion is comprised of a resiliently compressible material thereby facilitating vibration from the personal electronic device to be communicated through the cushion. In this way the cushion enhances comfort for the user by exposing the user to the vibration. | 2021-10-21 |
20210322260 | VIBRATIONAL MUSCLE MASSAGING SYSTEM - A vibrational muscle massaging system includes a tubular member that is elongated and has a first end, a second end, and a perimeter surface extending between the first and second ends. The tubular member comprises a substantially solid member. The tubular member comprises a foamed elastomer and is resiliently compressible. The tubular member has a cylindrical shape and has a length greater than a diameter. The first end has a well extending therein. The well has a width that is greater than the height. The well is configured to receive a cellular phone to frictionally engage the cellular phone such that cellular phone extends outwardly away from first end. The tubular member vibrates when the cellular phone vibrates. | 2021-10-21 |
20210322261 | VIBRATORY NERVE EXCITER - A laryngeal nerve exciting system includes a collar holding a bridge, or a neckband, pressing soft tissue nerve exciters against a patient's neck providing a source of vibrations to stimulate the laryngeal nerve through the larynx. At least one exciter, and preferably two exciters, provide vibrations at preferably 70 Hz to 110 Hz and sufficiently strong to penetrate to the laryngeal nerve. The exciters may be held by the collar circling the neck, or by the neck band partially circling the neck. The therapy system includes a Personal Digital Assistant (PDA) and software which wirelessly connects, monitors, and triggers the device. The system may be used to treat dysphagia, chronic cough, and spasmodic dysphonia. | 2021-10-21 |
20210322262 | VIBRATORY NERVE EXCITER - A laryngeal nerve exciting system includes a collar holding a bridge, or a neckband, pressing soft tissue nerve exciters against a patient's neck providing a source of vibrations to stimulate the laryngeal nerve through the larynx. At least one exciter, and preferably two exciters, provide vibrations at preferably 70 Hz to 110 Hz and sufficiently strong to penetrate to the laryngeal nerve. The exciters may be held by the collar circling the neck, or by the neck band partially circling the neck. The therapy system includes a Personal Digital Assistant (PDA) and software which wirelessly connects, monitors, and triggers the device. The system may be used to treat dysphagia, chronic cough, and spasmodic dysphonia. | 2021-10-21 |
20210322263 | METHODS OF VIBRATIONALLY EXCITING A LARYNGEAL NERVE - A laryngeal nerve exciting system includes a collar holding a bridge, or a neckband, pressing soft tissue nerve exciters against a patient's neck providing a source of vibrations to stimulate the laryngeal nerve through the larynx. At least one exciter, and preferably two exciters, provide vibrations at preferably 70 Hz to 110 Hz and sufficiently strong to penetrate to the laryngeal nerve. The exciters may be held by the collar circling the neck, or by the neck band partially circling the neck. The therapy system includes a Personal Digital Assistant (PDA) and software which wirelessly connects, monitors, and triggers the device. The system may be used to treat dysphagia, chronic cough, and spasmodic dysphonia. | 2021-10-21 |
20210322264 | METHODS AND SYSTEMS TO REDUCE BRAIN DAMAGE - A method to improve neurologically-intact survival rates after cardiac arrest may include performing CPR on an individual in cardiac arrest while the individual is in a supine position in general alignment with a horizontal plane. The method may include elevating the individual's head, shoulders, and heart relative to the individual's lower body while the individual's lower body remains generally aligned with the horizontal plane to cause blood to actively drain venous blood from the brain to reduce intracranial pressure. The method may include performing chest compressions on the individual and actively decompressing the individual's chest while the individual's head, shoulders, and heart are elevated. | 2021-10-21 |
20210322265 | Data Management System and Methods for Chest Compression Devices - A medical resuscitation system includes a platform for releasable coupling to a patient for delivery of mechanical chest compressions, the platform having sensor(s) for monitoring aspect(s) of compression delivery, and processing circuitry configured to control the delivery chest compressions during a patient therapy session; receive, during the session, signals from each sensor; and store, to a memory, operational data collected for use by an authorized user in troubleshooting a problem with the platform and/or gathering historic data regarding use of the platform, and clinical metrics regarding the delivery of the compressions during the session, where the clinical metrics are collected for use in a summary report accessible to a clinical user. The summary report may be transferred to a server or a portable computer readable medium. The operational data may be transferred to an accessory unit or data integrator configured to cooperate with the platform for providing the therapy. | 2021-10-21 |
20210322266 | PORTABLE HYDROTHERAPY APPARATUS - This invention relates to a portable bath and hydrotherapy apparatus, utilizing an electric or a battery-operated motor. More particularly, the invention relates to a portable hydrotherapy unit which can be used in conjunction with a bathtub or with other open-topped bodies adapted to be partially filled with a supply of liquid. The improved resultant of the present invention is the utilization of such a motor for hydrotherapy purposes whereby the unit re-circulates the water of the bathtub. | 2021-10-21 |
20210322267 | FLEXIBLE LINER WITH INNER AND OUTER LAYERS FOR USE WITH A LIQUID-RECEIVING BASIN - A liner for use with a basin to contain a liquid features a plurality of bodies of flexible plastic. Portions of an inner face of a first body of flexible plastic are joined to corresponding portions of an inner face of a second body of flexible plastic, through which a plurality of openings are formed, to provide a multi-layer body of flexible plastic. Other portions of the inner face of the first body of flexible plastic are not joined to corresponding other portions of the inner face of the second body of flexible plastic, defining an air conduit between the first body of flexible plastic and the second body of flexible plastic for guiding pressurized air substantially from an air discharge apparatus. | 2021-10-21 |
20210322268 | AURICULAR PERIPHERAL NERVE FIELD STIMULATOR AND METHOD OF OPERATING SAME - An auricular peripheral nerve field stimulator includes at least one therapy electrode configured for percutaneous insertion into an auricle of a human ear near at least one neurovascular bundle, and an electrical stimulation device electrically coupled to the at least one therapy electrode, the electrical stimulation device programmed to generate and deliver electrical stimulation signals, with defined stimulation parameters, to the percutaneously inserted at least one therapy electrode to stimulate at least one auricular peripheral nerve field within the auricle, the defined stimulation parameters including a defined signal amplitude, a defined pulse frequency, a defined pulse width, a defined duty cycle and a defined stimulation signal duration. | 2021-10-21 |
20210322269 | Acupressure Node Garment - Articles of clothing and accessories with one or more integrated nodes that facilitate application of pressure to one or more acupoints on the body of a person wearing the article. | 2021-10-21 |
20210322270 | ANTISEPTIC VIAL WITH REMOVABLE CAP - Medical vials and bottles containing medications dispensable syringes and needles are interfaced to replaceable caps having alcohol infused wipes therein to sterilize the rubber hubs through which the needles will be inserted into the vials to draw out the medication therefrom. | 2021-10-21 |
20210322271 | FLEXIBLE CONTAINER ASSEMBLY AND FITMENT ASSEMBLY FOR A FLEXIBLE CONTAINER ASSEMBLY - A flexible container assembly including a bag assembly and a fitment assembly. The bag assembly includes a bag and a spout. The spout includes a base flange and a cylindrical upstand that is in fluid communication with the cavity of the bag. The fitment assembly includes a body and a cap. The body includes a base, having an opening, a depending skirt depending from a lower surface of the base and a upstanding spout extending from the upper surface of the base. Methods of making, filling and using of the flexible container assembly, and the fitment assembly and components thereof are likewise disclosed. | 2021-10-21 |
20210322272 | TWO-CHAMBER TYPE COMBINED CONTAINER-SYRINGE - The present invention provides a two-chamber type combined container-syringe including: a cylinder having a first end portion, a second end portion in an opposite direction of the first end portion, and a bypass portion disposed between the first end portion and the second end portion; a finger grip mounted on the second end portion of the cylinder; a first stopper, a second stopper, and a third stopper that are sequentially disposed from the first end portion toward the second end portion in a space of the cylinder; and a plunger rod that is connected to the third stopper and has a plurality of support ribs provided to come in contact with an inner surface of the finger grip, wherein a space between the first stopper and the second stopper forms a front chamber, a space between the second stopper and the third stopper forms a rear chamber, a first ingredient and a second ingredient are accommodated in the front chamber and the rear chamber, respectively, a length ratio of the front chamber and the rear chamber is in a range of 1.6:1 to 3:1 when the plunger rod is at an initial position which is a state before the front chamber and the rear chamber communicate with each other through the bypass portion, and at the initial position, one or more support ribs are disposed in at least one of the finger grip and a region in the cylinder that is adjacent to the finger grip. | 2021-10-21 |
20210322273 | DRUG DELIVERY DEVICE HAVING CONTROLLED DELIVERY AND CONFIRMATION - A drug delivery device includes a capsule, a logic circuit disposed within the capsule, and an actuator connected to the logic circuit and configured to expose an interior of the capsule to an exterior of the capsule upon activation by the logic circuit. | 2021-10-21 |
20210322274 | Pill Sorting Apparatus - A novel apparatus for allocating pills from a pharmacy pill container into a weekly pill storage container is described herein. The pill sorting apparatus is made of two parts, each with seven holes. The pills are poured into the sorting apparatus, and the two parts are shifted so that the holes align, allowing the seven pills to drop into the weekly pill storage container. | 2021-10-21 |
20210322275 | SYSTEM FOR ADMINISTERING AND HEATING LIQUIDS - A device for heating and concomitantly administering a liquid includes a body having at opposite ends a base and a neck connectable to liquid suction means, and liquid heating means. The body has an inner housing configured to receive and completely enclose a liquid container. The inner housing has fluidic connection means. The neck has one or more tubes adapted to fluidically connect the fluidic connection means to the liquid suction means. The liquid heating means are adapted to heat at least partially the one or more tubes, and the fluidic connection means have one or more sharp spouts for puncturing of a predetermined region of the liquid container and for fluidic connection to the liquid container. A liquid container and a sanitizing system of the device are also provided. | 2021-10-21 |
20210322276 | VESSEL FOR A FLUID HAVING A SILICONE CONTINUITY - A vessel intended to contain a fluid including a container delimiting an inner volume made of a flexible material and topped with a tubular sleeve whose proximal end delimits a housing. The sleeve includes an upper shoulder projecting radially outwards of the sleeve. The vessel also comprises a removable closure device made of a flexible material including a lower shoulder adapted to interact with the upper shoulder of the sleeve so that tightness is ensured when the lower shoulder and the upper shoulder are compressed against one another. The vessel also comprises includes a coupling system enabling holding and mutual compression of the lower shoulder of the removable closure device and of the upper shoulder of the sleeve. | 2021-10-21 |
20210322277 | SIMULATED FLOW-CONTROL BREAST FEEDING SYSTEM - System comprising of a simulating flow control breastfeeding where a tube linking a refillable housing chamber to a prosthetic nipple, an analyzing module linked to a sensor to determine a physical, physiological, or emotional state of the infant/user by mapping the received input parameter with a pre-stored set of parameters from the parameter store via the analyzing module and dynamically interact with the infant/user based on a determined output to promote a non-latching simulating breastfeeding experience to prevent bruised, sore nipples or engorged breasts. | 2021-10-21 |
20210322278 | User controllable non-collapsable variable stream patterned nipple - A flow controllable and variable stream physiological dispenser for nursing and related bottle, including a nursing bottle, or a sports container, having a cap holding a nursing bottle nipple, or a spout, upon its upper end, the bottle or container may have a singular or double venting structure provided therein, so as to prevent aeration of its contents and eliminate the need for sucking pressure to attain fluid flow from the container. The nipple or spout has various slits, of varying lengths, in order to regulate the quantity of flow of liquid from the bottle, and which nipple may be reinforced through internally formed ribs. Indicia is provided for indicating a fast, intermediate, or slow rate of flow of formula from the bottle, and various apertures, slits, crosscuts, tangential cuts, may be provided at the apex of the nipple or spout to provide a standard constant flow of fluid from the associated container, and which may be supplemented through the flow of formula through the associated radial slits provided through the upper reaches of the nursing bottle nipple or spout. | 2021-10-21 |
20210322279 | BUTYRIC ACID BASED ASPIRATION DETECTION AND NASOGASTRIC OR INTUBATION PLACEMENT VERIFICATION PLATFORMS AND METHODS - A butyric acid detection based platform for verifying placement of a patient airway device or a gastric tube comprising at least one of i) a colorimetric based butyric acid detection platform, ii) a bioelectronic sensors based butyric acid detection platform using olfactory receptors, and iii) an IR based butyric acid detection platform. Each platform comprises a housing coupled to the patient airway device or gastric tube whereby flow from the coupled patient airway device or a gastric tube can flow through an internal passage of the housing; and wherein sensors within the housing come into contact with the flow from the coupled patient airway device or a gastric tube, the sensors including at least one of a chemical sensor array including at least one of i) colorimetric based butyric acid sensor, ii) a bioelectronic butyric acid detection sensor using olfactory receptors, and iii) an IR based butyric acid sensor. | 2021-10-21 |
20210322280 | FEEDING TUBE WITH INFLATABLE BALLOON COMPONENT AND AT LEAST ONE OF A CARBON DIOXIDE SAMPLING LINE AND A SUCTION TUBE COMPONENT - A feeding tube with an inflatable balloon component and at least one of (1) a carbon dioxide (CO | 2021-10-21 |
20210322281 | PACIFIER COVER AND TEETHER - A pacifier cover system, a pacifier cover, a teether, and a pacifier cover and teether device capable of being attached to a pacifier are disclosed herein. The pacifier cover can attach to a pacifier handle to add a decorative flare to the pacifier, to increase the size of the pacifier such that the pacifier is easier to find when lost or when a child drops the pacifier, and to create a larger area to grip by both the parents and child. The pacifier cover can also include raised bumps or protrusions for teething and to assist in gripping the device. The pacifier cover includes a connecting mechanism having a connector ring with an outer sidewall connected to a back surface of the pacifier cover, an upper surface connected to the outer sidewall, an inner surface connected to the upper surface, and a curved portion with a radius of curvature interconnected to the inner surface and forming a lip. The connector ring further having a cavity formed by a cavity wall extending downward from the curved portion, the cavity at least partly surrounded by the connector ring, where the cavity receives a portion of the pacifier handle when the pacifier cover is connected to the pacifier. | 2021-10-21 |
20210322282 | TEETHER WITH WRISTBAND - An objective of the present disclosure is to provide a teether, wherein the teether is prevented from twisting when the circumferential length of a band thereof worn around the wrist of an infant is adjusted so as to not harm the body of the infant and a comfortable fit around the wrist is ensured. | 2021-10-21 |
20210322283 | GLAZING COMPOSITION FOR A DENTAL ZIRCONIA ARTICLE, PROCESS OF SINTERING AND KIT OF PARTS - The invention relates to a glazing composition suitable for glazing the surface a dental zirconia article. The glazing composition comprises a liquid, glass particles, and hydrophilic silica nano-particles. The invention also relates to a process for sintering a porous dental zirconia article with a glazing composition on its surface. | 2021-10-21 |
20210322284 | DENTAL DESENSITIZER - A dental desensitizer, including, by weight: 1-20 parts of a protein modified by polyethylene glycol; 1-10 parts of tris(2-carboxyethyl) phosphine hydrochloride; 1-3 parts of calcium chloride; and 2-20 parts of a pH regulator. | 2021-10-21 |
20210322285 | PIGMENT MIXTURE - The present invention relates to a pigment mixture based on spherical particles having a defined particle-size distribution, and to the use thereof in paints, coatings, printing inks, security printing inks, plastics, ceramic materials, glasses, in cosmetic formulations, as tracer, as filler and for the preparation of pigment preparations and dry preparations. | 2021-10-21 |
20210322286 | TOPICAL COMPOSITIONS - The present invention relates generally to methods and compositions useful to cleanse, exfoliate, smooth, moisturize, hydrate, and/or improve the appearance and/or condition of skin and/or hair using a composition including shea butter, PEG-50 shea butter, and/or hydrated silica. | 2021-10-21 |
20210322287 | ORAL CARE PRODUCT COMPRISING AN ORAL CARE RHEOLOGICAL SOLID COMPOSITION - An oral care product including an oral care rheological solid composition including a crystallizing agent, an aqueous phase, and oral care adjunct ingredient. The oral care product can be a floss, a dentifrice, and/or a whitening product. A method for making an oral care rheological solid composition by providing water, providing crystallizing agent, providing NaCl in an amount of about 10% or less, by weight of the oral care rheological solid composition; and mixing the water, crystallizing agent, and NaCl to produce the oral care rheological solid composition. | 2021-10-21 |
20210322288 | Toothpaste Compositions Comprising Silica And Surface Active Polymer - An oral care composition with silica and polyvinylpyrrolidone showing an increased in viscosity after a shear event, viscosity recovery, of at least about 1.5× within approximately 348 seconds. A low-water oral care composition with improved rheology. A low-water oral care composition that does not leak from a toothpaste tube if inverted. An oral care composition with low water, silica, surface active polymer, and optionally polyphosphate. | 2021-10-21 |
20210322289 | SYNERGISTICALLY-ACTING COMPOSITIONS FOR MICROBE REDUCTION THAT COMPRISE AROMATIC ALCOHOL, GLYCERYL ETHER AND BISPYRIDINIUM ALKANE AND USE OF SUCH COMPOSITIONS - The invention relates to synergistically-acting compositions for microbe reduction that comprise an aromatic alcohol, glyceryl ether and bispyridinium alkane. The invention also relates to the use of the synergistically-acting compositions, for example for microbe reduction and/or preservation of cosmetic compositions. | 2021-10-21 |
20210322290 | Rheological Solid Composition for Use in Shaving - A rheological solid shave composition. The rheological solid shave composition has a crystallizing agent, an active and an aqueous phase. | 2021-10-21 |
20210322291 | COMPOUNDS AND METHODS FOR REPELLING BLOOD-FEEDING ARTHROPODS AND DETERRING THEIR LANDING AND FEEDING - This invention relates to a group of compounds for repelling blood-feeding ectoparasitic arthropods, and a method of deterring their landing and feeding on animals including humans, by applying in one or more formulations compounds that incorporate one or more sulfide and one or more hydroxyl groups to the skin, clothing or environment of animals, including humans. A method of repelling and deterring landing and feeding by blood-feeding arthropods on an animal by applying in effective amount one or more compounds that incorporate alkyl sulfide and alcohol moieties, or alkyl sulfide and amide moieties, or alkyl sulfide and amide moieties to the skin, clothing or environment of an animal. | 2021-10-21 |
20210322292 | MINERALIZATION AGENT AND MOUTH WASH COMPRISING THE SAME - A mineralization agent, including, by weight: 5-50% of a film-forming protein, 5-40% of an amelogenin peptide, 5-30% of a water-soluble phosphate, 4-20% of a tris(2-carboxyethyl) phosphine hydrochloride, and 1-10% of a pH regulator. The film-forming protein is selected from the group consisting of lysozyme, bovine serum protein, insulin, α-lactalbumin, or a mixture thereof. | 2021-10-21 |
20210322293 | GUAR HYDROXYPROPYLTRIMETHYLAMMONIUM CHLORIDE AND USES THEREOF IN HAIR TREATMENT COMPOSITIONS - The present invention relates to a non-cellulosic polysaccharide derivative: i) having a mean average molecular weight (Mw) from about 100,000 g/mol, preferably from about 150,000 g/mol and more preferably from about 200,000 g/mole to about 2,000,000 g/mol, preferably to about 1,800,000 g/mol and more preferably to about 1,400,000 g/mole; and ii) containing at least one cationic group, with a cationic degree of substitution (DS | 2021-10-21 |
20210322294 | COSMETIC COMPOSITION FOR IMPROVING SKIN CONDITION CONTAINING PEONY EXTRACT AS ACTIVE INGREDIENT FOR HEATSHOCK PROTEIN ACTIVATION - The present invention relates to a cosmetic composition which includes microcapsule particles (1 to 1,000 μm) stabilized by encapsulating a peony extract as an active ingredient, which is useful for skin, with a biocopolymer, and a fibrous protein surrounding the particles in a matrix form, a method of preparing the cosmetic composition, and the use of the cosmetic composition for improving a skin condition. | 2021-10-21 |
20210322295 | Cleansing Compositions - Described herein, are personal care compositions comprising a surfactant system; an amino acid, e.g. taurine; and a deposition aid comprising a PVM/MA copolymer having a M.W. of from about 30,000 to about 1,000,000, or a vinylimidazolium vinyl pyrrolidone copolymer. Methods of making and using these compositions are also described. | 2021-10-21 |
20210322296 | AQUEOUS DISPERSION COMPOSITION AND USE THEREOF - An aqueous dispersion composition in which hydrophobic powders are stably and uniformly dispersed in an aqueous phase, which has excellent handling workability, and which can exhibit sufficient water repellency, water resistance, sebum resistance, and the like when compounded in a cosmetic composition or the like is provided. The aqueous dispersion composition contains at least (A) carboxylic acid-modified silicone in a liquid form at 50° C., (B) a hydrophobic powder, (C) a basic substance, and (D) water; and optionally (E) one or more alcohols selected from polyhydric alcohols and ethyl alcohols; wherein 80% by mass or more of a total composition is formed of the components (A) to (E), and component (B) is contained in a range of 10% to 70% by mass of the total composition, and component (A) is contained in a range of 5 to 30 parts by mass with respect to 100 parts by mass of component (B). | 2021-10-21 |
20210322297 | COSMETIC COMPOSITIONS FOR PROTECTION AGAINST LIGHT-INDUCED DAMAGES - The invention relates to cosmetic compositions [compositions (C)] comprising an oak extract, a grape seed extract and a green tea extract and to the use of a composition (C) to protect body parts exposed to light against damages. It further relates to a cosmetic method [method (CM)] for protecting body parts exposed to light against damages, said method comprising applying a composition (C) to a body part exposed to light. | 2021-10-21 |
20210322298 | USE OF PLANT EXTRACTS IN COSMETICS - The cosmetic use of at least two extracts obtained from two vegetables selected from | 2021-10-21 |
20210322299 | SKIN CARE FORMULATION - There is provided a skin care formulation for transdermal administration of a component of a blood product, the formulation comprising a blood product, a transdermal carrier; and a liposomal base, wherein at least a portion of the blood product and transdermal carrier is contained within liposomes of the liposomal base. | 2021-10-21 |
20210322300 | LOW POWER, CHEMICALLY AMPLIFIED, ELECTRICALLY REMOVABLE BARRIER - An implantable device contains a drug or biosensing compound, protected from the external environment within a human body by several barriers which are broken upon activation of the device through electrothermal, chemical, and mechanical processes. The device allows accurate and repeated dosing within a human body, thus reducing the number of implantation procedures required. This device extends the lifetime of a biosensor, reducing the number of implantation procedures required. | 2021-10-21 |
20210322301 | DOSING REGIMENS FOR TREATING METAL-MEDIATED CONDITIONS - The present disclosure provides safe and effective dosing regimens of metal chelators as treatment for metal overload disorders and, in particular, iron overload and associated conditions. | 2021-10-21 |
20210322302 | METHOD FOR MORSELIZING AND/OR TARGETING PHARMACEUTICALLY ACTIVE PRINCIPLES TO SYNOVIAL TISSUE - A method of targeting to the synovial tissue biodegradable drug delivery compositions or morselizing biodegradable drug delivery compositions are described. The biodegradable drug composition comprises a triblock copolymer containing a polyester and a polyethylene glycol and a diblock copolymer containing a polyester and an end-capped polyethylene glycol, as well as at least one pharmaceutically active principle is disclosed. | 2021-10-21 |
20210322303 | LIPID EMULSION FOR PARENTERAL NUTRITION COMPRISING GPC - The present disclosure relates to parenteral nutritional formulations, including ready-to-use parenteral nutrition formulations. More particularly, the present disclosure is directed to lipid formulations or emulsions and multi-chamber containers comprising same, wherein the lipid emulsion contains glycerophosphorylcholine as a choline source. The present disclosure further relates to methods of providing choline to a patient in need of parenteral nutrition and methods of avoiding and/or treating choline deficiency and liver damage. | 2021-10-21 |
20210322304 | STABLE READY-TO-USE CARMUSTINE PHARMACEUTICAL COMPOSITION - The present invention relates to a ready-to-use solution of carmustine that does not require dissolution or dilution of the carmustine prior to addition to saline and dextrose parenteral solutions. In particular, the invention relates to a stable liquid pharmaceutical composition containing carmustine in the form of ready-to-use solution and method for preparing the same. | 2021-10-21 |
20210322305 | Methods and Compositions for Oral Administration of Exenatide - This invention provides compositions comprising a byetta, fish oil, and a protease inhibitor, method for treating diabetes mellitus, comprising administering same, and methods for oral or rectal administration of a byetta. | 2021-10-21 |
20210322306 | ORAL DISSOLVABLE FILM WITH HIGH LOAD OF POLYMERIC BINDER - The present invention relates to an oral dissolvable film (ODF), methods of orally administering the same, and methods of manufacturing the same. The ODF includes a high load of binder. Such an ODF, containing a high load of binder, can achieve the requisite physical and performance characteristics and can be manufactured on a commercial scale, while demonstrating that the ODF is safe and effective to consumers for its intended use. This also includes formulating and configuring the ODF to deliver the API as desired, via, e.g., enteral, transmucosal, sublingual, and/or buccal, when the administration is oral. | 2021-10-21 |
20210322307 | METHOD AND COMPOSITION FOR MAKING AN ORAL SOLUBLE FILM, CONTAINING AT LEAST ONE ACTIVE AGENT - A method of making an oral soluble film, containing at least one active agent, includes providing a well of a predetermined size; depositing a film forming composition in the well; depositing an active agent composition in the well, the active agent composition being different than the film forming composition, the film forming composition and the active agent composition forming an admixture in the well; and drying the admixture in the well. Alternatively, the method includes providing a well of a predetermined size; depositing a film forming composition including at least one active agent in the well, the film forming composition having a viscosity below 2000 centipoise; and drying the film forming composition in the well. | 2021-10-21 |
20210322308 | NOVEL PHARMACEUTICAL FORMULATIONS - The present invention relates to new extended release pharmaceutical compositions and methods of use thereof for the treatment of disorders. | 2021-10-21 |
20210322309 | Inhalable Formulation of a Solution Containing Olodaterol - The present invention relates to a liquid, propellant-free pharmaceutical preparation and a method for administering the pharmaceutical preparation by nebulizing the pharmaceutical preparation in an inhaler. The propellant-free pharmaceutical preparation comprises: (a) Olodaterol; (b) a solvent; (c) an isoosmotic adjusting agent; (d) a pH adjusting agent, and optionally including other pharmacologically acceptable additives. | 2021-10-21 |
20210322312 | CANNABIDIOL COMPOSITION AND METHODS THEREOF - The present invention relates to a composition comprising cannabidiol (CBD) and a pharmaceutically acceptable carrier thereof in the form of a cream. The present invention further relates to methods of treating pain or inflammation by administering a therapeutically effective amount of the composition of the present invention to a subject in need thereof. The present invention also relates to a kit comprising the cannabidiol composition and a method of making the cannabidiol composition. | 2021-10-21 |
20210322313 | In-case stand for a musical instrument - An in-case stand for a musical instrument that supports a musical instrument in the open musical instrument case, such as a guitar, in an inclined position making the headstock and the neck readily accessible for string changes, cleaning or light maintenance. | 2021-10-21 |
20210322314 | Use Of Liposomes To Deliver A Protein And A Gene Encoding The Protein To A Live Cell - The present invention provides compositions and methods for treating a cancer using liposomes. Collectively, the liposomes contain a protein and a vector encoded for a gene corresponding to the protein. The amount of the protein and the vector a plurality of liposome is sufficiently effective to treat cancer cells. At least some of the liposomes can contain an antibody that recognizes, and thereby targets, a protein expressed on the cancer cell. | 2021-10-21 |
20210322315 | PROCESS FOR THE PRODUCTION OF LIPIDIC VEHICLES - Process for the production of lipidic vehicles comprising providing a mixture of an amphiphilic lipid and a promoter in a liquid medium comprising water and a liquid polyol, stirring and heating the mixture in two heating steps, wherein the temperature of the second heating step is higher than the temperature of the first heating step and allowing the mixture to cool down to room temperature. | 2021-10-21 |
20210322316 | ZINC MELOXICAM COMPLEX MICROPARTICLES AND ANESTHETIC FORMULATIONS AND PROCESSES FOR MAKING THE SAME - Embodiments of the present disclosure are related to sustained-release delivery vehicle formulations encapsulating zinc meloxicam complex microparticles with amide-type anesthetics. Methods of making the zinc meloxicam complex microparticles and administering the zinc meloxicam complex microparticles with varying anesthetics encapsulated in delivery vehicle formulations and their use as medicaments are also provided. | 2021-10-21 |
20210322317 | FORMATION OF PARTICLES INCLUDING AGENTS - The invention provides methods for the preparation of particles including one or more agents, e.g., therapeutic or diagnostic agents. The particles can be formed by creating droplets of a first liquid, e.g., including an agent, and removing the first liquid, e.g., through its dispersal in a second liquid and/or evaporation, to solidify the droplets. Advantageously, the process of forming the particles does not significantly alter the structure or activity of the agents and may enhance the stability of the agents. For example, the particles may be stored for long periods of time without significant loss of activity, and in some embodiments, without the need for refrigeration. These particles may be used to generate stabilized pharmaceutical compositions for storage or other logistical purposes, pharmaceutical suspensions, pharmaceutical powder formulations (e.g., inhalable powders, injectable powders), creams or other topical pastes, nutraceuticals, or cosmetics. | 2021-10-21 |
20210322318 | PROCESSES FOR MAKING CYCLIC LIPID IMPLANTS FOR INTRAOCULAR USE - Biocompatible implants comprising a cyclic lipid therapeutic agent are made using a low temperature melt extrusion process. The implants are suitable for intraocular use to treat an ocular condition. | 2021-10-21 |
20210322319 | A PHARMACEUTICAL FORMULATION FOR ORAL ADMINISTRATION WITH IMPROVED CONTENT UNIFORMITY COMPRISING SUSTAINED-RELEASE PELLETS CONTAINING TAMSULOSIN HYDROCHLORIDE - Provided is an oral pharmaceutical formulation including sustained-release pellets containing tamsulosin hydrochloride and a pharmaceutically acceptable additive, wherein the sustained-release pellets includes about 50 wt % to about 100 wt % of particles having a particle size of about 0.50 mm to about 0.85 mm, and less than about 15 wt % of particles having a particle size less than about 0.50 mm. The oral pharmaceutical formulation may have a reduced deviation in dissolution rate of tamsulosin hydrochloride and improved content uniformity among unit dosage forms, and have ensured quality due to high reproducibility of unit dosage forms. | 2021-10-21 |
20210322320 | APPARATUS AND METHOD FOR CRYOGRANULATING A PHARMACEUTICAL COMPOSITION - Cryogranulation systems with improved dispenser assemblies are provided for use in manufacturing frozen pellets of pharmaceutical substances in a fluid medium. Methods of cryogranulating the pharmaceutical substance in the fluid medium are also provided. In particular embodiments, the dispenser assembly is used with suspensions or slurries of pharmaceutical compositions including biodegradable substances, such as proteins, peptides, and nucleic acids. In certain embodiments, the pharmaceutical substance can be adsorbed to any pharmaceutically acceptable carrier particles suitable for making pharmaceutical powders. In one embodiment, the pharmaceutical carrier can be, for example, diketopiperazine-based microparticles. The dispenser assembly improves the physical characteristics of the cryopellets formed and minimizes product loss during processing. | 2021-10-21 |
20210322321 | Tamper-resistant drug dosage forms and methods of making and use thereof - A tamper resistant drug dosage is described. The drug dosage form includes a matrix polymer, a scaffold polymer, and a therapeutic agent, and the porosity of the drug dosage form is less than 10%. Methods for making and using the tamper resistant drug dosage forms are described. | 2021-10-21 |
20210322322 | RHEOLOGICAL SOLID ORAL COMPOSITION - A rheological solid oral composition comprising a crystallizing agent, an aqueous phase, and an oral active agent. | 2021-10-21 |
20210322323 | PHARMACEUTICAL COMPOSITION FOR ORAL ADMINISTRATION COMPRISING AMINOPYRIMIDINE DERIVATIVE OR PHARMACEUTICALLY ACCEPTABLE SALT, HYDRATE, OR SOLVATE THEREOF - Provided herein are pharmaceutical compositions for oral administration comprising N-(5-(4-(4-((dimethylamino)methyl)-3-phenyl-1H-pyrazol-1-yl)pirimidine-2-ylamino)-4-methoxy-2-morpholinophenyl)acrylamide or a pharmaceutically acceptable salt, hydrate, or solvate thereof as an active ingredient; and a combination of (i) a cellulose derivative and (ii) a sugar or polyol as diluents. The disclosed compositions are characterized by improved manufacturability, while maintaining the pharmaceutical benefits of minimizing the effect according to changes in pH environment in the stomach, possessing excellent stability, and exhibiting good bioavailability. | 2021-10-21 |
20210322324 | METHOD FOR TREATING PRIMARY SCLEROSING CHOLANGITIS - The invention relates to the use of pharmaceutical compositions of the SGLT2 inhibitor, remogliflozin etabonate, to treat primary sclerosing cholangitis (PSC). Methods and compositions associated with the invention can improve or maintain clinical outcomes of PSC symptoms, such as ascites accumulation, hepatic encephalopathy, development of varices, jaundice, variceal bleeding, cholangiocarcinoma, hepatocellular carcinoma, evidence of cirrhosis, and colorectal cancer. | 2021-10-21 |
20210322325 | CONTROLLED DRUG RELEASE FORMULATION - Pharmaceutical formulation dosage form ( | 2021-10-21 |
20210322326 | HYDROGEL PARTICLE CARRIERS FOR DELIVERY OF THERAPEUTIC/DIAGNOSTIC AGENTS - Particles for delivery of therapeutic agents are disclosed. In one embodiment, a particle for delivery of a therapeutic agent includes a hydrogel polymer matrix, a plurality of hydrophobic encapsulation sites within the hydrogel polymer matrix, and a hydrophobic therapeutic agent encapsulated within at least some of the encapsulation sites. The hydrogel polymer matrix may be hydrophilic. The hydrophobic encapsulation sites may comprise cyclodextrin conjugated to the hydrogel polymer matrix. The hydrogel polymer matrix comprises gelatin. The particle may have a diameter of 10 nm to 50 μm. | 2021-10-21 |
20210322327 | EXTRACELLULAR VESICLES COMPRISING STING-AGONIST - Provided herein are compositions comprising EV, e.g., exosome, encapsulated STING agonists and methods of producing the compositions described. Also provided herein are methods of modulating an immune response via administration of a therapeutic amount of EV, e.g., exosomes encapsulating STING agonists. The immune response may be an IENβ response or activation of myeloid dendritic cells (mDCs). Also provided herein are methods of modulating an immune response that does not induce systemic inflammation via administration of exosomes encapsulating STING agonists. | 2021-10-21 |
20210322328 | NANOSTRUCTURE LIPID SYSTEM - The present invention is related to systems of administration of enzymes or other proteins, preferably for use in enzyme replacement therapy (ERT), in particular for the treatment of Lysosomal diseases. In particular, the invention encompasses the preparation of a composition based on nanostructured lipid systems and its use in the manufacture of a therapeutic product. | 2021-10-21 |
20210322329 | NANOSTRUCTURED NANOPARTICLES COMPRISING ONE OR MORE ACTIVE INGREDIENTS FOR THE TREATMENT OF DISEASES CAUSED BY TRYPANOSOMES AND FOR THE TREATMENT OF TUMOURS OF NEURAL ORIGIN, COMPOSITIONS COMPRISING SAME, A PREPARATION METHOD AND THERAPEUTIC USE THEREOF - Pharmaceutical composition of antineoplastic and anti-tumor action, and method of obtaining it, wherein said composition comprises structured lipid nanoparticles that are between 0.1 nm and 100 nm in diameter, spheroidal in shape and contain particles of one or more active substances for the treatment of diseases produced by tripanosomes and for the treatment of tumors of neural origin, and at least one coupling of two fatty acids consisting of a saturated fatty acid or semi-solid lipid at the temperature between 19° C. and 21° C. and an unsaturated or liquid fatty acid at the temperature between 19° C. and 21° C. and in turn the method of obtaining finally contains the nanoparticles of one or more active substances for trypanosomiasis in colloidal suspension, the Z potential ranges from −30 to +30, preferably +8, the particles measured by Z-sizer and ultramicroscopy have from 0.1 nanometers to 100 nanometers, preferably 1 nanometer in diameter and spheroidal shape. | 2021-10-21 |
20210322330 | siRNA Nanocapsule and Preparation Method and Use thereof - The present disclosure provides an siRNA nanocapsule and a preparation method and use thereof, relating to the technical field of biomedical engineering. The siRNA nanocapsule provided in the present disclosure includes siRNA and a shell encapsulating the siRNA and polymerized by a monomer A and a monomer B. The monomer A has a double bond at one end, and is electrostatically bound with the siRNA, and the monomer B includes molecules for improving tumor microenvironment sensitivity. The siRNA nanocapsule provided in the present disclosure is suitable for a wide range of clinical applications. | 2021-10-21 |
20210322331 | NANOCAPSULES FOR THE DELIVERY OF CELL MODULATING AGENTS - The present disclosure is directed to polymer nanocapsules including a ribonucleoprotein complex, and methods of their delivery. In some embodiments, the polymer nanocapsule comprises a polymer shell and a ribonucleoprotein complex, wherein the polymer shell comprises at least one positively charged monomer, at least one neutral monomer, and a crosslinker. Also disclosed are conjugates of polymer nanocapsules coupled to one or more targeting moieties and/or one or more stabilizing moieties. | 2021-10-21 |
20210322332 | STATIN-ENCAPSULATED NANOPARTICLE PREPARATION, DENTAL PULP-DERIVED STEM CELLS CONTAINING SAME, AND CELL PREPARATION CONTAINING SUCH STEM CELLS - The present invention pertains to a technology for improving the function of stem cells used as cell preparations and enables the improvement of therapeutic effects on diseases. The present invention is a statin-encapsulated nanoparticle preparation which is for enhancing the function of dental pulp-derived stem cells, and which contains statin-encapsulated nanoparticles in which a statin is encapsulated in nanoparticles that include a bioabsorbable polymer. | 2021-10-21 |
20210322333 | Lignin-PLGA Biopolymers and Nanoparticles, and their Synthesis and Use - Amphiphilic biopolymers have been synthesized by grafting lignin onto PLGA to form graft polymers, which can then be further assembled into polymeric nanoparticles without a requirement for surfactants. The nanoparticles have a typical diameter of 75 nm. The nanoparticles may be used, for example, for drug delivery, including efficient and effective drug delivery against cancers such as triple negative breast cancers. | 2021-10-21 |
20210322334 | CHITOSAN GELS (A) CONTAINING METAL NANOPARTICLES OF COPPER, SILVER AND ANTIBIOTICS (CIPROFLOXACIN, CEFOTAXIME, GENTAMICIN AND CLOXACILLIN) - The present invention describes chitosan gel (poly-beta-glucosamine) having bacteriocidal and fungicidal properties in a mixture with nanoparticles of copper and/or silver, and/or antibiotics (ciprofloxacin, cloxacillin, gentamicin and cefotamine, and a mixture of ciprofloxacin and cloxacillin, gentamicin and cefotaxim), and a process of obtaining and using the described gel. | 2021-10-21 |
20210322335 | NANOPARTICLE COMPRISING RAPAMYCIN AND ALBUMIN AS ANTICANCER AGENT - The present invention features methods for treating, stabilizing, preventing, and/or delaying cancer by administering nanoparticles that comprise rapamycin or a derivative thereof. The invention also provides compositions (e.g., unit dosage forms) comprising nanoparticles that comprise a carrier protein and rapamycin or a derivative thereof. The invention further provides combination therapy methods of treating cancer comprising administering to an individual an effective amount of nanoparticles that comprise rapamycin or a derivative thereof and a second therapy. | 2021-10-21 |
20210322336 | METHOD FOR PREPARING ALBUMIN NANOPARTICLES BASED ON FREE RADICAL OXIDATION - A method for preparing albumin nanoparticles based on free radical oxidation, comprising the following steps: preparing albumin aqueous solution with an albumin concentration of 1-20 mg/mL; (2) whilst stirring, adding free radical generating agent to the albumin aqueous solution, and continuing to stir and react for 1-60 min at 15-50° C.; the free radicals generated by the free radical generating agent are used for oxidizing the albumin, and the oxidized albumin molecules assemble to form albumin nanoparticles that are mainly bonded by hydrophobic action, thereby obtaining an albumin nanoparticle suspension. The present invention implements improvement by means of the key reaction mechanism of the nanoparticle preparation method and the corresponding design of the finishing process and, compared to the prior art, can effectively solve the problems of the complexity, high cost, and high toxicity of preparing nanoparticles. | 2021-10-21 |
20210322337 | TREATMENT OF OXIDATIVE STRESS DISORDERS INCLUDING CONTRAST NEPHROPATHY, RADIATION DAMAGE AND DISRUPTIONS IN THE FUNCTION OF RED CELLS - Methods of treating or suppressing oxidative stress diseases and symptoms related to oxidative stress affecting normal electron flow in the cells or caused by reactive oxygen species with redox-active therapeutics. Use of redox-active therapeutics for the reduction, suppression or treatment of oxidative stress induced by chemical agents such as contrast agents and other nephrotoxic agents, by radiation exposure, and by disruptions in the transport of oxygen to tissues, is disclosed. | 2021-10-21 |
20210322338 | COMPOSITIONS COMPRISING CBD FOR TREATING DERMATOLOGICAL CONDITIONS - The present invention provides compositions and methods for the treatment of skin lesions. In particular, embodiments of the invention provide topical compositions useful in the treatment and alleviation of cutaneous symptoms associated with psoriasis, dermatitis and other dermatological conditions including ulcers or lesions, wherein the compositions contain CBD oil. | 2021-10-21 |
20210322339 | COMBINATION THERAPY OF COENZYME Q10 AND RADIATION FOR TREATMENT OF GLIOMA - The invention provides methods and compositions for treatment of a subject with a glioma. The methods comprise administering a composition comprising Coenzyme Q10 to the subject by continuous intravenous infusion; and administering radiation therapy to the subject. The composition comprising Coenzyme Q10 may be administered to the subject by continuous intravenous infusion for at least 24 hours before the radiation therapy is initiated. | 2021-10-21 |
20210322340 | STRESS TEST AND TREATMENT OF CHRONIC KIDNEY DISEASE - The present invention involves a novel method for treatment of chronic kidney disease comprising administering a compound that induces a stress protein response in a patient, and administering a potent antioxidant if the patent's response is below a predefined level. It also involves a quantitative measure for determining a patient's antioxidant reserve capacity. | 2021-10-21 |
20210322341 | LOW DOSAGE SEROTONIN 5-HT2A RECEPTOR AGONIST TO SUPPRESS INFLAMMATION - Activation of 5-HT | 2021-10-21 |
20210322342 | ENDOXIFEN FOR THE TREATMENT OF BIPOLAR I DISORDER - A method for managing or decreasing a risk of adverse effects in a patient undergoing treatment of bipolar I disorder is provided. The said method includes maintaining the therapeutically effective concentration of endoxifen by administrating a dose of 2 mg to 16 mg of endoxifen citrate in an enteric coated tablet once per day for at least 21 days. Further, adverse effects of alteration in thyroid functions, and thrombocytopenia can be avoided. | 2021-10-21 |
20210322343 | NASALLY ADMINISTERED PHARMACEUTICAL COMPOSITION FOR THE TREATMENT OF EPILEPSY AND RELATED DISORDERS - A nasally administered liquid, including suspension and viscous liquid compositions, containing a therapeutically effective quantity of (Z)-2-(3,5,5-trimethyl-2-cyclohexen-1-ylidene) acetic acid, its salts or analogs, combined with suitable pharmaceutical ingredients, to treat epilepsy. | 2021-10-21 |
20210322344 | NASALLY ADMINISTERED PHARMACEUTICAL COMPOSITION FOR THE TREATMENT OF EPILEPSY AND RELATED DISORDERS - A nasally administered liquid, including suspension and viscous liquid compositions, containing a therapeutically effective quantity of (Z)-2-(3,5,5-trimethyl-2-cyclohexen-1-ylidene) acetic acid, its salts or analogs, combined with suitable pharmaceutical ingredients, to treat epilepsy. | 2021-10-21 |
20210322345 | MIDODRINE HYDROCHLORIDE ORAL SOLUTION AND USES THEREOF - The invention provides oral liquid midodrine formulation and uses thereof. | 2021-10-21 |
20210322346 | CHEMICALLY MODIFIED CURCUMINS FOR USE IN THE PRODUCTION OF LIPOXINS - A method of increasing production of one or more lipoxins in a subject in need thereof comprising administering to the subject an amount of a compound having the structure: | 2021-10-21 |
20210322347 | THERAPEUTIC COMPOUNDS, FORMULATIONS, AND USES THEREOF - Provided herein are compositions, formulations, and (e.g., oral) dosage forms comprising a compound of Formula (I). In specific instances, such compositions comprise an emulsifier, a solubilizer, a polyethylene glycol, a surfactant, and an antioxidant. In some instances, such compositions are useful for the treatment of fibrosis, cancer, and/or chronic inflammation. | 2021-10-21 |
20210322348 | METHODS OF ADMINISTERING GAMMA-HYDROXYBUTYRATE COMPOSITIONS WITH DIVALPROEX SODIUM - Oral pharmaceutical compositions of gamma-hydroxybutyrate (GHB) suitable for concomitant administration with a dose of divalproex sodium (DVP) without materially altering the dosage amount of either drug are provided. Also provided are therapeutic uses of the compositions for the treatment of one or more symptoms of narcolepsy. | 2021-10-21 |
20210322349 | COMPOSITION OF (D)-Beta-HYDROXYBUTYRIC ACID, (D)-Beta-HYDROXYVALERIC ACID, AND (D)-1,3 BUTANEDIOL - A composition and method of increasing ketotic efficiency and improving flavor of a combination of a (D)-β-hydroxybutyric acid and (D)-1,3 butanediol composition for increasing circulating ketone levels is disclosed. Exemplary compositions may be incorporated into food, supplement, and beverage products. | 2021-10-21 |
20210322350 | EXOGENOUS KETONE SUPPLEMENTATION COMPOSITIONS, SYSTEMS AND METHODS - The claimed invention addresses the benefits of exogenous ketone supplementation in a subject in need thereof. In particular, the exogenous ketone supplementation includes the natural D-Beta HydroxyButyric acid, also described as natural D-BHB. As detailed in representative FIG. | 2021-10-21 |
20210322351 | VIDOFLUDIMUS FOR USE IN THE TREATMENT OR PREVENTION OF VIRAL DISEASES - The present invention relates to a compound according to Formula (I) | 2021-10-21 |
20210322352 | COMPOSITION FOR IMPROVING ENDURANCE AND METHOD OF IMPROVING ENDURANCE USING THE SAME - Technical Problem | 2021-10-21 |
20210322353 | NUTRITIONAL COMPOSITION FOR THE TREATMENT OF METABOLIC DISEASES - A composition for preventing or treating a metabolic disease, in particular phenylketonuria, comprising sulfur amino acids and minerals is provided, wherein said sulfur amino acids comprise a combination of methionine and cysteine in a methionine/cysteine ratio of 2.2-2.7:1 and said minerals comprise sodium, potassium, magnesium, calcium, chlorine, phosphorus. The composition of the invention is formulated to provide a negative PRAL value, preferably with −352021-10-21 | |
20210322354 | METHODS OF TREATING INFLAMMATORY, FIBROTIC, AND PROLIFERATIVE CONDITIONS USING COMPOSITIONS COMPRISING DGLA AND/OR 15-HETRE, AND ASSOCIATED METHODS AND COMPOSITIONS - The present disclosure provides orally and/or topically deliverable pharmaceutical compositions comprising DGLA or a derivative thereof and/or 15-HETrE or a derivative thereof and methods of using same to treat a variety of conditions, diseases, and disorders, including but not limited to inflammatory, fibrotic, and proliferative conditions, diseases, and disorders. | 2021-10-21 |
20210322355 | MODULATORS OF PROSTATE-SPECIFIC G-PROTEIN RECEPTOR (PSGR/OR51E2) AND METHODS OF USING SAME - The present disclosure provides, in part, modulators of prostate-specific G-protein receptor (OR51E2/PSGR) and methods of treating, preventing, and diagnosing prostate cancer using the same. | 2021-10-21 |
20210322356 | Misoprostol Dispersible Tablet - The present invention relates to a solid pharmaceutical formulation comprising misoprostol or a pharmaceutically acceptable salt thereof. In particular, the invention relates to a dispersible tablet comprising misoprostol or a pharmaceutically acceptable salt thereof. | 2021-10-21 |